Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lifeway Foods ( (LWAY) ) just unveiled an update.
Lifeway Foods, a leader in probiotic kefir products, has rejected Danone’s $27 per share acquisition offer, deeming it undervalued. The company highlights its robust growth and strong financial performance, including a 788% shareholder return over five years and a projected EBITDA of $45-50 million by 2027. Lifeway’s board believes its standalone strategy offers superior value, driven by consumer interest in gut health and operational efficiencies.
See more data about LWAY stock on TipRanks’ Stock Analysis page.